메뉴 건너뛰기




Volumn 20, Issue 4, 2004, Pages 262-263

Successful electroconvulsive treatment of depression associated with a marked reduction in the symptoms of tardive dyskinesia

Author keywords

Electroconvulsive therapy; Major depression; Tardive dyskinesia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ETIZOLAM; FLUNITRAZEPAM; FLUVOXAMINE; HYPNOTIC AGENT; LITHIUM CARBONATE; MILNACIPRAN; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; SULPIRIDE; TRIHEXYPHENIDYL;

EID: 10344228221     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200412000-00014     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0002217686 scopus 로고
    • Neurological symptoms in pharmacotherapy of psychoses
    • Faurbye A, Rasch PJ, Petersen PB, et al. Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr Scand. 1964;40:10-27.
    • (1964) Acta Psychiatr Scand , vol.40 , pp. 10-27
    • Faurbye, A.1    Rasch, P.J.2    Petersen, P.B.3
  • 2
    • 0028872044 scopus 로고
    • Antidepressant-induced tardive dyskinesia: Review and case report
    • Clayton AH. Antidepressant-induced tardive dyskinesia: review and case report. Psychopharmacol Bull. 1995;31:259-264.
    • (1995) Psychopharmacol Bull , vol.31 , pp. 259-264
    • Clayton, A.H.1
  • 3
    • 0037349634 scopus 로고    scopus 로고
    • Antipsychotic drug-induced movement disorders
    • Blanchet PJ. Antipsychotic drug-induced movement disorders. Can J Neurol Sci. 2003;30:S101-S107.
    • (2003) Can J Neurol Sci , vol.30
    • Blanchet, P.J.1
  • 4
    • 10344242605 scopus 로고
    • Tardive Dyskinesia: Clinical features
    • Wolf ME, Mosnaim AD eds. Washington, DC: American Psychiatric Association Press
    • Singh H, Simpson GM. Tardive Dyskinesia: Clinical features. In: Wolf ME, Mosnaim AD eds. Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects. Washington, DC: American Psychiatric Association Press; 1981;67-86.
    • (1981) Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects , pp. 67-86
    • Singh, H.1    Simpson, G.M.2
  • 5
    • 0021013932 scopus 로고
    • Prevalence of tardive dyskinesia in affective disorder patients
    • Yassa R, Ghadirian AM, Schwartz G. Prevalence of tardive dyskinesia in affective disorder patients. J Clin Psychiatry. 1983;44:410-412.
    • (1983) J Clin Psychiatry , vol.44 , pp. 410-412
    • Yassa, R.1    Ghadirian, A.M.2    Schwartz, G.3
  • 6
    • 14444272517 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitor-induced movement disorders
    • Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother. 1998;32:692-698.
    • (1998) Ann Pharmacother , vol.32 , pp. 692-698
    • Gerber, P.E.1    Lynd, L.D.2
  • 7
    • 70449264103 scopus 로고
    • Observations on the effect of electroshock treatment in patients with Parkinsonism
    • Fromm CH. Observations on the effect of electroshock treatment in patients with Parkinsonism. Bull Tulane Univ Med Facility. 1959;18:71-73.
    • (1959) Bull Tulane Univ Med Facility , vol.18 , pp. 71-73
    • Fromm, C.H.1
  • 8
    • 0017147177 scopus 로고
    • Improvement of depression and parkinsonism during ECT: A case study
    • Dysken M, Evans HM, Chan CH, et al. Improvement of depression and parkinsonism during ECT: a case study. Neuropsychobiology. 1976;2: 81-86.
    • (1976) Neuropsychobiology , vol.2 , pp. 81-86
    • Dysken, M.1    Evans, H.M.2    Chan, C.H.3
  • 9
    • 0023895363 scopus 로고
    • Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease
    • Burke WJ, Peterson J, Rubin EH. Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease. Psychosomatics. 1988;29:341-346.
    • (1988) Psychosomatics , vol.29 , pp. 341-346
    • Burke, W.J.1    Peterson, J.2    Rubin, E.H.3
  • 10
    • 0032942169 scopus 로고    scopus 로고
    • Management of Parkinson's disease a review of current and new therapies
    • Mendis T, Suchowersky O, Lang A, et al. Management of Parkinson's disease a review of current and new therapies. Can J Neurol Sci. 1999;26: 89-103.
    • (1999) Can J Neurol Sci , vol.26 , pp. 89-103
    • Mendis, T.1    Suchowersky, O.2    Lang, A.3
  • 11
    • 0017818520 scopus 로고
    • The effects of electroconvulsive therapy on tardive dyskinesia
    • Price TR, Levin R. The effects of electroconvulsive therapy on tardive dyskinesia. Am J Psychiatry. 1978;135:991-993.
    • (1978) Am J Psychiatry , vol.135 , pp. 991-993
    • Price, T.R.1    Levin, R.2
  • 12
    • 0019157618 scopus 로고
    • Treatment of tardive dyskinesia in an agitated, depressed patient
    • Rosenbaum AH, O'Connor MK, Duane DD, et al. Treatment of tardive dyskinesia in an agitated, depressed patient. Psychosomatics. 1980;21: 765-766.
    • (1980) Psychosomatics , vol.21 , pp. 765-766
    • Rosenbaum, A.H.1    O'Connor, M.K.2    Duane, D.D.3
  • 13
    • 0020604935 scopus 로고
    • ECT and tardive dyskinesia: Two cases and a review
    • Chacko RC, Root L. ECT and tardive dyskinesia: two cases and a review. J Clin Psychiatry. 1983;44:265-266.
    • (1983) J Clin Psychiatry , vol.44 , pp. 265-266
    • Chacko, R.C.1    Root, L.2
  • 14
    • 0023845132 scopus 로고
    • Improvement of tardive dyskinesia associated with electroconvulsive therapy
    • Gosek E, Weller RA. Improvement of tardive dyskinesia associated with electroconvulsive therapy. J Nerv Ment Dis. 1988;176:120-122.
    • (1988) J Nerv Ment Dis , vol.176 , pp. 120-122
    • Gosek, E.1    Weller, R.A.2
  • 16
    • 84891024436 scopus 로고
    • Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy
    • Uhrbrand L, Faurbye A. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia. 1960;1:408-418.
    • (1960) Psychopharmacologia , vol.1 , pp. 408-418
    • Uhrbrand, L.1    Faurbye, A.2
  • 17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.